We briefly review the genetic basis of Alport syndrome, discuss genetic counseling issues associated with carrier identification, and present potential pathways for the evaluation and management of people found to have a pathogenic/likely pathogenic (P/LP) variant in COL4A3, COL4A4, or COL4A5 on carrier screening. Here, COL4A3 is linked to Alport syndrome.